On October 20, Unitree Robotics made an announcement stating that the deviation in the closing price of its stock over three consecutive trading days—October 16, October 19, and October 20—exceeded 30%. This surge triggered the abnormal trading monitoring criteria set by the STAR Market. Following a thorough self-inspection, the company, in conjunction with its controlling shareholder and actual controller, affirmed that there was no significant information that should have been disclosed but remained undisclosed. Additionally, they confirmed that the company's current operational status is proceeding normally. As of October 20, the company's trailing price-to-earnings (P/E) ratio was recorded at 388.25 times, markedly higher than the industry average of 39.51 times. Given that the humanoid robot industry is still in the nascent stages of commercialization, if large-scale commercialization fails to meet expectations, the company's future revenue and performance could be adversely affected, thereby posing a risk of valuation correction.